These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 11816257)

  • 1. Celecoxib-induced nonoliguric acute renal failure.
    Alkhuja S; Menkel RA; Alwarshetty M; Ibrahimbacha AM
    Ann Pharmacother; 2002 Jan; 36(1):52-4. PubMed ID: 11816257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Celecoxib-induced acute interstitial nephritis.
    Henao J; Hisamuddin I; Nzerue CM; Vasandani G; Hewan-Lowe K
    Am J Kidney Dis; 2002 Jun; 39(6):1313-7. PubMed ID: 12046048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Case report: reversible acute renal failure following therapy with both ketorolac (non-selective non-steroidal anti-inflammatory drug NSAID) and celecoxib (COX-2 selective) in the same patient].
    Galli G; Panzetta G
    G Ital Nefrol; 2002; 19(2):199-203. PubMed ID: 12195419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Celecoxib-induced nephrotoxicity in a renal transplant recipient.
    Clifford TM; Pajoumand M; Johnston TD
    Pharmacotherapy; 2005 May; 25(5):773-7. PubMed ID: 15899741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Renal tolerance of selective inhibitors of cyclooxygenase type 2].
    Deray G
    Presse Med; 2001 Oct; 30(30):1507-12. PubMed ID: 11712212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metformin-induced lactic acidosis and acute pancreatitis precipitated by diuretic, celecoxib, and candesartan-associated acute kidney dysfunction.
    Audia P; Feinfeld DA; Dubrow A; Winchester JF
    Clin Toxicol (Phila); 2008 Feb; 46(2):164-6. PubMed ID: 18259965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Celecoxib versus diclofenac and omeprazole in reducing the risk of recurrent ulcer bleeding in patients with arthritis.
    Chan FK; Hung LC; Suen BY; Wu JC; Lee KC; Leung VK; Hui AJ; To KF; Leung WK; Wong VW; Chung SC; Sung JJ
    N Engl J Med; 2002 Dec; 347(26):2104-10. PubMed ID: 12501222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Severe cutaneous drug reactions to celecoxib (Celebrex)].
    Marquès S; Milpied B; Foulc P; Barbarot S; Cassagnau E; Stalder JF
    Ann Dermatol Venereol; 2003 Nov; 130(11):1051-5. PubMed ID: 14724542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Celecoxib for rheumatoid arthritis.
    Megeff CE; Strayer SM
    J Fam Pract; 2000 Feb; 49(2):108-9. PubMed ID: 10718683
    [No Abstract]   [Full Text] [Related]  

  • 10. Update on clinical developments with celecoxib, a new specific COX-2 inhibitor: what can we expect?
    Geis GS
    Scand J Rheumatol Suppl; 1999; 109():31-7. PubMed ID: 10422544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiorenal effects of celecoxib as compared with the nonsteroidal anti-inflammatory drugs diclofenac and ibuprofen.
    Whelton A; Lefkowith JL; West CR; Verburg KM
    Kidney Int; 2006 Oct; 70(8):1495-502. PubMed ID: 16941030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Warfarin and celecoxib interaction.
    Mersfelder TL; Stewart LR
    Ann Pharmacother; 2000 Mar; 34(3):325-7. PubMed ID: 10917378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Current status of COX II inhibitors in therapy of rheumatoid arthritis in comparison with conventional non-steroidal anti-inflammatory agents. Attempt at an evaluation with regard to evidence-based medicine].
    Krüger K
    Z Rheumatol; 2001 Dec; 60(6):481-4. PubMed ID: 11826746
    [No Abstract]   [Full Text] [Related]  

  • 14. Migratory pulmonary infiltrates in a patient with rheumatoid arthritis.
    Mehandru S; Smith RL; Sidhu GS; Cassai N; Aranda CP
    Thorax; 2002 May; 57(5):465-7. PubMed ID: 11978928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What's all the fuss? Safety concerns about COX-2 inhibitors rofecoxib (Vioxx) and celecoxib (Celebrex).
    Wooltorton E
    CMAJ; 2002 Jun; 166(13):1692-3. PubMed ID: 12126328
    [No Abstract]   [Full Text] [Related]  

  • 16. Celecoxib: a COX-2 inhibitor.
    Andrews SA; Wallace CK; Davis RL
    Am J Manag Care; 1999 Apr; 5(4):511-8; quiz 522-4. PubMed ID: 10387389
    [No Abstract]   [Full Text] [Related]  

  • 17. COX-2 inhibitors. Magic bullets or merely mortal?
    Harv Health Lett; 2000 Feb; 25(4):4. PubMed ID: 10637015
    [No Abstract]   [Full Text] [Related]  

  • 18. [Coxibs: highly selective cyclooxygenase-2 inhibitors. Part II. Side effects].
    Burdan F; Korobowicz A
    Pol Merkur Lekarski; 2003 Apr; 14(82):352-5. PubMed ID: 12868201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of rofecoxib, celecoxib, and naproxen on renal function in elderly subjects receiving a normal-salt diet.
    Schwartz JI; Vandormael K; Malice MP; Kalyani RN; Lasseter KC; Holmes GB; Gertz BJ; Gottesdiener KM; Laurenzi M; Redfern KJ; Brune K
    Clin Pharmacol Ther; 2002 Jul; 72(1):50-61. PubMed ID: 12152004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gastrointestinal safety of amtolmetin guacyl in comparison with celecoxib in patients with rheumatoid arthritis.
    Jajić Z; Malaise M; Nekam K; Koó E; Dankó K; Kovacs M; Scarpignato C
    Clin Exp Rheumatol; 2005; 23(6):809-18. PubMed ID: 16396699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.